跳至主要内容
临床试验/NL-OMON54672
NL-OMON54672招募中不适用

Faecal microbiota transfusion for decolonization of multidrug resistant Enterobacteriaceae in renal transplant recipients (RESET): a pilot study. - RESET

eids Universitair Medisch Centrum0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria: 1. Competent renal transplant recipient aged 18 or
  • above. 2. Intestinal carriage of extended-spectrum β-lactamase
  • Enterobacteriaceae (ESBL-E) and/or carbapenemase producing Enterobacteriaceae
  • (CPE) by rectal swab or stool culture tests (>=2x). 3. A history of >= 1
  • documented infection by these bacteria <6 months before enrolment. 4.
  • Adequate understanding of the procedures of the study and agrees to abide
  • strictly thereby. 5. Ability to communicate well with the investigators and
  • availability attend all study visits. 6. Signed informed consent.

排除标准

  • 1. Need for systemic antibiotics. 2. ICU admission at enrolment. 3. Creatinine
  • clearance <30 ml/min. 4. (Planned) pregnancy during study. 5. Allergy /
  • contraindication study drugs. 6. Recurrent aspirations / chronic dysphagia. 7.
  • Recent intra-abdominal surgery. 8. A history of acute rejection within 6 months
  • before enrolment. 9. Treatment with alemtuzumab within 6 months before
  • enrolment. 10. Treatment with of eculizumab within 3 months before enrolment.
  • 11. Clinical signs of active colitis / gastro-enteritis, including active
  • infections (EBV /CMV / adenovirus / Clostridium difficile / chronic parasitic
  • infection) or active inflammatory bowel disease. 12. Severe food allergy.

研究者

相似试验